2005 sales of Pfizer Korea slow at 255,300 million won.

Published: 2006-03-06 06:56:00

Updated: 2006-03-06 06:56:00

Pfizer Korea reported 2005 business performances as 255,300 MW of sales, about 0.93% down from the previous year, 44,780 MW of operating income, 2.02% up, 63,863 MW of ordinary income, which was 6,000 MW more than the previous year and 19,048 MW of net income, 12.12% up from the previous year.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK